Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Natalizumab benefits QOL in multiple sclerosis

    • 12 Accesses

    This is a preview of subscription content, log in to check access.

    REFERENCE

    1. 1.

      Kieseier B, Putzki N, Bates D, Hutchinson M, Pace A, Hyde R.Improvement in quality-of-life outcomes with natalizumab in multiple sclerosis patients with highly active disease. 61st Annual Meeting of the American Academy of Neurology: abstr. P05.137, 29 Apr 2009

    2. 2.

      Foley JF.The efficacy of natalizumab in patients with relapsing multiple sclerosis in a clinical practice setting. 61st Annual Meeting of the American Academy of Neurology: abstr. P05.140, 29 Apr 2009

    3. 3.

      Stephenson JJ, Rajagopalan K, Agarwal SS, Kamat SA.Change in health-related quality of life in multiple sclerosis patients receiving natalizumab. 61st Annual Meeting of the American Academy of Neurology: abstr. P05.144, 29 Apr 2009

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Natalizumab benefits QOL in multiple sclerosis. Pharmacoecon. Outcomes News 577, 9 (2009). https://doi.org/10.2165/00151234-200905770-00022

    Download citation

    Keywords

    • Visual Analogue Scale
    • Physical Component Summary
    • Mental Component Summary
    • Natalizumab
    • Mental Component Summary Score